Annual CFI
-$19.76 M
-$5.95 M-43.04%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual cash flow from investing activities is -$19.76 million, with the most recent change of -$5.95 million (-43.04%) on December 31, 2023.
- During the last 3 years, GYRE annual CFI has fallen by -$11.57 million (-141.25%).
- GYRE annual CFI is now -141.25% below its all-time high of -$8.19 million, reached on December 1, 2021.
Performance
GYRE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$2.39 M
+$5.89 M+71.15%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly cash flow from investing activities is -$2.39 million, with the most recent change of +$5.89 million (+71.15%) on September 30, 2024.
- Over the past year, GYRE quarterly CFI has dropped by -$3.73 million (-278.27%).
- GYRE quarterly CFI is now -278.27% below its all-time high of $1.34 million, reached on December 31, 2023.
Performance
GYRE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$16.54 M
+$3.01 M+15.41%
September 30, 2024
Summary
- As of February 7, 2025, GYRE TTM cash flow from investing activities is -$16.54 million, with the most recent change of +$3.01 million (+15.41%) on September 30, 2024.
- Over the past year, GYRE TTM CFI has increased by +$3.22 million (+16.29%).
- GYRE TTM CFI is now -429.75% below its all-time high of -$3.12 million, reached on March 1, 2022.
Performance
GYRE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GYRE Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.0% | -278.3% | +16.3% |
| 3 y3 years | -141.3% | +68.8% | -116.3% |
| 5 y5 years | -141.3% | +68.8% | -116.3% |
GYRE Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -141.3% | at low | -278.3% | +71.2% | -429.8% | +21.6% |
| 5 y | 5-year | -141.3% | at low | -278.3% | +71.2% | -429.8% | +21.6% |
| alltime | all time | -141.3% | at low | -278.3% | +71.2% | -429.8% | +21.6% |
Gyre Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.39 M(-71.1%) | -$16.54 M(-15.4%) |
| Jun 2024 | - | -$8.27 M(+14.6%) | -$19.55 M(+1.1%) |
| Mar 2024 | - | -$7.22 M(-639.2%) | -$19.33 M(-2.2%) |
| Dec 2023 | -$19.76 M | $1.34 M(-124.8%) | -$19.76 M(-6.3%) |
| Sep 2023 | - | -$5.40 M(-32.9%) | -$21.10 M(+34.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$8.05 M(+5.3%) | -$15.70 M(+105.3%) |
| Mar 2023 | - | -$7.65 M(+144.9%) | -$7.65 M(+144.9%) |
| Dec 2022 | -$13.81 M(+68.7%) | - | - |
| Mar 2022 | - | -$3.12 M | -$3.12 M |
| Dec 2021 | -$8.19 M | - | - |
FAQ
- What is Gyre Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Gyre Therapeutics?
- What is Gyre Therapeutics annual CFI year-on-year change?
- What is Gyre Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly CFI year-on-year change?
- What is Gyre Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Gyre Therapeutics?
- What is Gyre Therapeutics TTM CFI year-on-year change?
What is Gyre Therapeutics annual cash flow from investing activities?
The current annual CFI of GYRE is -$19.76 M
What is the all time high annual CFI for Gyre Therapeutics?
Gyre Therapeutics all-time high annual cash flow from investing activities is -$8.19 M
What is Gyre Therapeutics annual CFI year-on-year change?
Over the past year, GYRE annual cash flow from investing activities has changed by -$5.95 M (-43.04%)
What is Gyre Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of GYRE is -$2.39 M
What is the all time high quarterly CFI for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly cash flow from investing activities is $1.34 M
What is Gyre Therapeutics quarterly CFI year-on-year change?
Over the past year, GYRE quarterly cash flow from investing activities has changed by -$3.73 M (-278.27%)
What is Gyre Therapeutics TTM cash flow from investing activities?
The current TTM CFI of GYRE is -$16.54 M
What is the all time high TTM CFI for Gyre Therapeutics?
Gyre Therapeutics all-time high TTM cash flow from investing activities is -$3.12 M
What is Gyre Therapeutics TTM CFI year-on-year change?
Over the past year, GYRE TTM cash flow from investing activities has changed by +$3.22 M (+16.29%)